- Global Ibuprofen prices followed a mixed-to-firm trend during Q1’26 as fluctuating upstream chemical costs, elevated energy prices, and logistics disruptions supported the market despite cautious pharmaceutical procurement.
- Feedstock pressure remained volatile due to changing acetone and propylene market conditions, while the Iran war and disruptions around the Strait of Hormuz increased freight, utility, and production expenses across pharmaceutical supply chains.
- Downstream demand from OTC medicines, pain management drugs, hospital procurement, and seasonal healthcare consumption remained stable, although distributors maintained cautious inventory strategies.
Asia
In Asia, Ibuprofen prices initially strengthened during Q1’26 due to higher feedstock costs and improving pharmaceutical manufacturing activity before softening mid-quarter amid weaker procurement and rising inventories. Expanding phenol-acetone production capacity in China continued influencing upstream market dynamics and feedstock availability, creating fluctuations in acetone pricing sentiment during the quarter. However, by March, the Iran conflict and disruptions around the Strait of Hormuz sharply increased energy and shipping expenses, raising production and export costs for pharmaceutical intermediates and supporting a late-quarter recovery in Ibuprofen prices. Stable export activity from China and improving regional pharmaceutical manufacturing further supported market fundamentals across Asia.
Europe
In Europe, Ibuprofen prices remained relatively elevated as manufacturers faced higher import and logistics expenses alongside uncertain feedstock availability. Weak downstream chemical demand and low operating rates in parts of the European acetone market intermittently tightened spot supply conditions during the quarter. Rising freight charges, marine insurance premiums, and concerns over energy flows through the Strait of Hormuz further increased replacement costs for imported pharmaceutical feedstocks and intermediates. Demand from healthcare and OTC pharmaceutical sectors remained stable, preventing significant price declines despite cautious procurement behaviour among distributors.
North America
In North America, Ibuprofen prices stayed firm as elevated upstream acetone costs and stable pharmaceutical demand supported the market. Production-side tightness in the acetone market and healthy export activity from the US Gulf region strengthened overall pharmaceutical intermediate costs during the quarter. Consumption from pain relief, cold and flu medication, and hospital procurement channels remained consistent, while higher global freight and energy costs linked to the Iran conflict limited opportunities for downward price correction.